Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ken H Young

Showing results (1-10 of 294) with videos related to

Pageof 30
Sort By:
Leukemia|May 14, 2020
Good prognosis or poor prognosis, dose-intensive or less intensive: who decides for adults with T-lymphoblastic lymphoma/leukemiaKen H Young
Cancer Communications (London, England)|February 19, 2021
Intensive chemotherapy and sequential hematopoietic stem cell transplantation: Is it necessary for high-risk T-cell lymphoblastic lymphoma?Ken H Young
Leukemia|October 24, 2019
Hematopoietic stem cell transplantation for adults with T-cell lymphoblastic lymphoma: can we successfully step into the era of precision medicine?Ken H Young
Leukemia & Lymphoma|March 2, 2021
Hepatitis B virus antibody status provides new insights in diffuse large B-Cell lymphomaXiaosheng Fang, Ken H Young
Nature Reviews. Clinical Oncology|November 28, 2013
Haematological cancer: Richter's transformation in CLL-a distinct lymphomaPreetesh Jain, Ken H Young
Blood Science (Baltimore, Md.)|July 4, 2025
A promising leap in treating large granular lymphocytic leukemia: reflections on a Multicenter Phase II Study of thalidomide-based therapyXue Kong, Ken H Young
Cancer Treatment Reviews|March 1, 2017
Targeting the programmed death-1 pathway in lymphoid neoplasmsChi Young Ok, Ken H Young
Journal of Hematology & Oncology|May 10, 2017
Checkpoint inhibitors in hematological malignanciesChi Young Ok, Ken H Young
Aging|July 19, 2015
Age cutoff in lymphoma diagnosisChi Young Ok, Ken H Young
Critical Reviews in Oncogenesis|April 2, 2018
Oncogenic Signaling Pathways and Pathway-Based Therapeutic Biomarkers in Lymphoid MalignanciesRuifang Sun, Jinfen Wang, Ken H Young
Pageof 30

Showing results (1-10 of 294) with videos related to

Sort By:
Pageof 30
Leukemia|May 14, 2020
Good prognosis or poor prognosis, dose-intensive or less intensive: who decides for adults with T-lymphoblastic lymphoma/leukemiaKen H Young
Cancer Communications (London, England)|February 19, 2021
Intensive chemotherapy and sequential hematopoietic stem cell transplantation: Is it necessary for high-risk T-cell lymphoblastic lymphoma?Ken H Young
Leukemia|October 24, 2019
Hematopoietic stem cell transplantation for adults with T-cell lymphoblastic lymphoma: can we successfully step into the era of precision medicine?Ken H Young
Leukemia & Lymphoma|March 2, 2021
Hepatitis B virus antibody status provides new insights in diffuse large B-Cell lymphomaXiaosheng Fang, Ken H Young
Nature Reviews. Clinical Oncology|November 28, 2013
Haematological cancer: Richter's transformation in CLL-a distinct lymphomaPreetesh Jain, Ken H Young
Blood Science (Baltimore, Md.)|July 4, 2025
A promising leap in treating large granular lymphocytic leukemia: reflections on a Multicenter Phase II Study of thalidomide-based therapyXue Kong, Ken H Young
Cancer Treatment Reviews|March 1, 2017
Targeting the programmed death-1 pathway in lymphoid neoplasmsChi Young Ok, Ken H Young
Journal of Hematology & Oncology|May 10, 2017
Checkpoint inhibitors in hematological malignanciesChi Young Ok, Ken H Young
Aging|July 19, 2015
Age cutoff in lymphoma diagnosisChi Young Ok, Ken H Young
Critical Reviews in Oncogenesis|April 2, 2018
Oncogenic Signaling Pathways and Pathway-Based Therapeutic Biomarkers in Lymphoid MalignanciesRuifang Sun, Jinfen Wang, Ken H Young
Pageof 30